Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lolke de Haan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Molecular Membrane Biology|June 19, 2004
Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review)Lolke De Haan, Timothy R Hirst
Current Opinion in Drug Discovery & Development|April 3, 2002
Bacterial toxins as versatile delivery vehiclesLolke de Haan, Timothy R Hirst
Infection and Immunity|May 16, 2002
Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathwayLolke De Haan, Arron R Hearn, A Jennifer Rivett, et al.
The Journal of Biological Chemistry|September 3, 2004
Trafficking of exogenous peptides into proteasome-dependent major histocompatibility complex class I pathway following enterotoxin B subunit-mediated deliveryArron R Hearn, Lolke de Haan, Alexander J Pemberton, et al.
Current Opinion in Pharmacology|August 28, 2012
Monoclonal antibody therapeutics: history and futureNicholas A P S Buss, Simon J Henderson, Mary McFarlane, et al.
Drug Discovery Today|August 15, 2013
Current challenges and opportunities in nonclinical safety testing of biologicsSven Kronenberg, Andreas Baumann, Lolke de Haan, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2014
New challenges and opportunities in nonclinical safety testing of biologicsAndreas Baumann, Kelly Flagella, Roy Forster, et al.
Frontiers in Immunology|March 20, 2023
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized miceAlba Matas-Céspedes, Jean-Martin Lapointe, Matthew J Elder, et al.
Regulatory Toxicology and Pharmacology : RTP|September 1, 2016
Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new InsightsGuenter Blaich, Andreas Baumann, Sven Kronenberg, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular Membrane Biology|June 19, 2004
Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review)Lolke De Haan, Timothy R Hirst
Current Opinion in Drug Discovery & Development|April 3, 2002
Bacterial toxins as versatile delivery vehiclesLolke de Haan, Timothy R Hirst
Infection and Immunity|May 16, 2002
Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathwayLolke De Haan, Arron R Hearn, A Jennifer Rivett, et al.
The Journal of Biological Chemistry|September 3, 2004
Trafficking of exogenous peptides into proteasome-dependent major histocompatibility complex class I pathway following enterotoxin B subunit-mediated deliveryArron R Hearn, Lolke de Haan, Alexander J Pemberton, et al.
Current Opinion in Pharmacology|August 28, 2012
Monoclonal antibody therapeutics: history and futureNicholas A P S Buss, Simon J Henderson, Mary McFarlane, et al.
Drug Discovery Today|August 15, 2013
Current challenges and opportunities in nonclinical safety testing of biologicsSven Kronenberg, Andreas Baumann, Lolke de Haan, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2014
New challenges and opportunities in nonclinical safety testing of biologicsAndreas Baumann, Kelly Flagella, Roy Forster, et al.
Frontiers in Immunology|March 20, 2023
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized miceAlba Matas-Céspedes, Jean-Martin Lapointe, Matthew J Elder, et al.
Regulatory Toxicology and Pharmacology : RTP|September 1, 2016
Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new InsightsGuenter Blaich, Andreas Baumann, Sven Kronenberg, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
Pageof 3